ABVX Stock Summary and Trading Ideas (Abivax SA - American Depositary Shares | NASDAQ:ABVX)

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. The company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD. The Group operates in a single operating segment: R&D of pharmaceutical products in order to market them in the future.

What symbol and exchange does Abivax SA - American Depositary Shares shares trade?

Abivax SA - American Depositary Shares trades on the NASDAQ stock market under the symbol ABVX.

What is Abivax SA - American Depositary Shares stock price doing today?

As of June 17, 2026, ABVX stock price climbed to $100.15 with 1,528,841 million shares trading.

What is Abivax SA - American Depositary Shares's Beta?

ABVX has a beta of 2.86, meaning it tends to be more sensitive to market movements. ABVX has a correlation of 0.03 to the broad based SPY ETF.

How much is Abivax SA - American Depositary Shares worth?

ABVX has a market cap of $7.98 billion. This is considered a Mid Cap stock.

How much money does Abivax SA - American Depositary Shares make?

Last quarter Abivax SA - American Depositary Shares reported $5 million in Revenue and -$5.45 earnings per share. This fell short of revenue expectation by $-348,000 and missed earnings estimates by -$.54.

What are the top ETFs holding Abivax SA - American Depositary Shares?

The top ETF exchange traded funds that ABVX belongs to (by Net Assets): IBB, MSSM, ONEQ, ATFV, MEDI.

Is Abivax SA - American Depositary Shares (ABVX) a good investment?

ABVX has outperformed the market in the last year with a price return of +1390.3% while the SPY ETF gained +24.2%. However, in the short term, ABVX had mixed performance relative to the market. It has underperformed in the last 3 months, returning -18.4% vs +11.0% return in SPY. But in the last 2 weeks, ABVX shares have fared better than the market returning +38.1% compared to SPY -2.5%.

What are the support and resistance levels for Abivax SA - American Depositary Shares (ABVX)?

ABVX support price is $92.73 and resistance is $102.27 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ABVX shares will trade within this expected range on the day.